# | Title | Journal | Year | Citations |
---|
1 | The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal | Journal of Gastrointestinal Oncology | 2012 | 493 |
2 | Colorectal carcinoma: Pathologic aspects | Journal of Gastrointestinal Oncology | 2012 | 385 |
3 | Gastric cancer: Classification, histology and application of molecular pathology | Journal of Gastrointestinal Oncology | 2012 | 368 |
4 | Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy | Journal of Gastrointestinal Oncology | 2017 | 235 |
5 | Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition | Journal of Gastrointestinal Oncology | 2018 | 192 |
6 | Gastrointestinal stromal tumors: a comprehensive review | Journal of Gastrointestinal Oncology | 2018 | 157 |
7 | Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity | Journal of Gastrointestinal Oncology | 2011 | 151 |
8 | Exosome can prevent RNase from degrading microRNA in feces | Journal of Gastrointestinal Oncology | 2011 | 145 |
9 | Impact of the immune system and immunotherapy in colorectal cancer | Journal of Gastrointestinal Oncology | 2015 | 142 |
10 | Patient selection for hepatic resection for metastatic colorectal cancer | Journal of Gastrointestinal Oncology | 2012 | 131 |
11 | The gut microbiome and colorectal cancer: a review of bacterial pathogenesis | Journal of Gastrointestinal Oncology | 2018 | 128 |
12 | BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies | Journal of Gastrointestinal Oncology | 2015 | 128 |
13 | Updates on immunotherapy for colorectal cancer | Journal of Gastrointestinal Oncology | 2018 | 126 |
14 | Viral hepatitis and hepatocellular carcinoma: etiology and management | Journal of Gastrointestinal Oncology | 2017 | 120 |
15 | Health disparities in colorectal cancer among racial and ethnic minorities in the United States | Journal of Gastrointestinal Oncology | 2016 | 119 |
16 | Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery | Journal of Gastrointestinal Oncology | 2017 | 115 |
17 | Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience | Journal of Gastrointestinal Oncology | 2018 | 110 |
18 | Hepatic metastasis from colorectal cancer | Journal of Gastrointestinal Oncology | 2019 | 108 |
19 | Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets | Journal of Gastrointestinal Oncology | 2019 | 106 |
20 | Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review | Journal of Gastrointestinal Oncology | 2019 | 105 |
21 | Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features | Journal of Gastrointestinal Oncology | 2012 | 98 |
22 | Gastrointestinal stromal tumor | Journal of Gastrointestinal Oncology | 2012 | 95 |
23 | Imaging of pancreatic cancer: An overview | Journal of Gastrointestinal Oncology | 2011 | 85 |
24 | The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1 | Journal of Gastrointestinal Oncology | 2016 | 84 |
25 | Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials | Journal of Gastrointestinal Oncology | 2014 | 84 |
26 | Immunohistochemical features of the gastrointestinal tract tumors | Journal of Gastrointestinal Oncology | 2012 | 83 |
27 | Imaging preoperatively for pancreatic adenocarcinoma | Journal of Gastrointestinal Oncology | 2015 | 82 |
28 | Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis | Journal of Gastrointestinal Oncology | 2017 | 81 |
29 | Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres | Journal of Gastrointestinal Oncology | 2015 | 81 |
30 | Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy | Journal of Gastrointestinal Oncology | 2016 | 80 |
31 | Molecular profiling of biliary tract cancer: a target rich disease | Journal of Gastrointestinal Oncology | 2016 | 79 |
32 | Diet and supplements and their impact on colorectal cancer | Journal of Gastrointestinal Oncology | 2013 | 79 |
33 | Techniques of hepatic resection | Journal of Gastrointestinal Oncology | 2012 | 76 |
34 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy | Journal of Gastrointestinal Oncology | 2016 | 75 |
35 | Diagnosis and management of cystic lesions of the pancreas | Journal of Gastrointestinal Oncology | 2015 | 73 |
36 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality | Journal of Gastrointestinal Oncology | 2016 | 71 |
37 | Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review | Journal of Gastrointestinal Oncology | 2017 | 68 |
38 | Surgical technology and pharmacology of hyperthermic perioperative chemotherapy | Journal of Gastrointestinal Oncology | 2016 | 68 |
39 | Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer | Journal of Gastrointestinal Oncology | 2017 | 67 |
40 | Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management | Journal of Gastrointestinal Oncology | 2021 | 66 |
41 | Understanding and targeting resistance to anti-angiogenic therapies | Journal of Gastrointestinal Oncology | 2013 | 66 |
42 | Stereotactic body radiation therapy for liver metastases | Journal of Gastrointestinal Oncology | 2014 | 66 |
43 | Impact of somatic mutations on patterns of metastasis in colorectal cancer | Journal of Gastrointestinal Oncology | 2015 | 66 |
44 | The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma | Journal of Gastrointestinal Oncology | 2021 | 65 |
45 | Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma | Journal of Gastrointestinal Oncology | 2016 | 64 |
46 | Locoregional and systemic therapy for hepatocellular carcinoma | Journal of Gastrointestinal Oncology | 2017 | 64 |
47 | Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients | Journal of Gastrointestinal Oncology | 2017 | 62 |
48 | HIFU for palliative treatment of pancreatic cancer | Journal of Gastrointestinal Oncology | 2011 | 62 |
49 | State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment | Journal of Gastrointestinal Oncology | 2015 | 62 |
50 | Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations | Journal of Gastrointestinal Oncology | 2015 | 61 |